GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 165 filers reported holding GENMARK DIAGNOSTICS INC in Q1 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $748,000 | -55.0% | 31,300 | -73.3% | 0.00% | -75.0% |
| Q3 2020 | $1,661,000 | -21.3% | 117,135 | -18.6% | 0.00% | -20.0% |
| Q2 2020 | $2,111,000 | +241.6% | 143,934 | -4.3% | 0.01% | +150.0% |
| Q1 2020 | $618,000 | +64.4% | 150,338 | +91.3% | 0.00% | +100.0% |
| Q4 2019 | $376,000 | +89.9% | 78,606 | +140.6% | 0.00% | – |
| Q3 2019 | $198,000 | +0.5% | 32,677 | +7.8% | 0.00% | – |
| Q2 2019 | $197,000 | -83.4% | 30,321 | -81.8% | 0.00% | -100.0% |
| Q1 2019 | $1,184,000 | +16.7% | 167,030 | -20.1% | 0.00% | 0.0% |
| Q4 2018 | $1,015,000 | -13.9% | 209,170 | +30.6% | 0.00% | 0.0% |
| Q3 2018 | $1,179,000 | +7.2% | 160,168 | -7.2% | 0.00% | 0.0% |
| Q2 2018 | $1,100,000 | +29.7% | 172,512 | +10.7% | 0.00% | +100.0% |
| Q1 2018 | $848,000 | +30.9% | 155,901 | +3.2% | 0.00% | 0.0% |
| Q4 2017 | $648,000 | -8.3% | 150,998 | +105.6% | 0.00% | 0.0% |
| Q3 2017 | $707,000 | -21.0% | 73,453 | +2.5% | 0.00% | -50.0% |
| Q4 2016 | $895,000 | – | 71,639 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|